The oral therapy is intended for adults with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis, two fibrotic lung diseases with limited treatment options.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-oks-new-option-pulmonary-fibrosis-2026a1000gte?src=rss
Author :
Publish date : 2026-05-22 17:23:00
Copyright for syndicated content belongs to the linked Source.
